LPK-26
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-(3,4-dichlorophenyl)-N-[(2S)-1-(2,5-dihydropyrrol-1-yl)-3-methylbutan-2-yl]-N-methylacetamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 492451-07-7 |
| ATC code | ? |
| PubChem | CID 10043746 |
| Chemical data | |
| Formula | C18H24Cl2N2O |
| Mol. mass | 355.301 g/mol |
| SMILES | eMolecules & PubChem |
| |
LPK-26 is a drug which acts as a potent and selective κ-opioid agonist, and has analgesic effects.[1]
[edit] References
- ^ Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, Chi ZQ, Long YQ, Liu JG (April 2008). "LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential". European Journal of Pharmacology 584 (2-3): 306–11. doi:10.1016/j.ejphar.2008.02.028. PMID 18353307.
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |

